What is Subclinical Atherosclerosis on Imaging?
Subclinical atherosclerosis on imaging refers to the detection of structural atherosclerotic changes in arterial walls in asymptomatic individuals without clinical symptoms or prior cardiovascular events 1, 2.
Definition and Imaging Manifestations
Subclinical atherosclerosis represents the presence of measurable atherosclerotic disease burden before it causes ischemic symptoms like myocardial infarction, stroke, or chronic limb-threatening ischemia 2. This is fundamentally different from clinical atherosclerosis, where plaque burden has progressed to cause symptoms.
Key Imaging Findings That Define Subclinical Atherosclerosis:
Coronary Arteries:
- Coronary artery calcium (CAC) score >0 - indicates presence of coronary atherosclerosis 3, 4
- Non-calcified coronary plaques detected on coronary CT angiography 1, 5
- An Agatston score of 0 has nearly 100% negative predictive value for ruling out significant coronary atherosclerosis 3
Carotid Arteries:
- Carotid intima-media thickness (CIMT) >0.9-1.0 mm 3, 6
- Visible arterial wall plaques (focal structure ≥0.5 mm or >50% of surrounding IMT, or any IMT ≥1.5 mm) 3, 7
- CIMT >75th percentile for age, sex, and ethnicity 6, 8
Peripheral Arteries:
- Ankle-brachial index (ABI) <0.9 - indicates ≥50% stenosis between aorta and distal leg arteries with 79% sensitivity and high specificity 3, 6
Aorta:
- Increased aortic wall thickness on MRI or ultrasound 9
Clinical Significance
The presence of subclinical atherosclerosis fundamentally changes risk stratification. Imaging-defined subclinical atherosclerosis identifies individuals at higher cardiovascular risk than predicted by traditional risk scores alone 1, 10. This discordance between clinical risk calculators (Framingham, pooled cohort equations) and actual atherosclerotic burden is well-established 1.
Prognostic Value by Modality:
Coronary calcium scoring is the most validated imaging measure of risk in asymptomatic individuals 1, 4. Each 0.1 mm increase in CIMT associates with 10% increased MI risk and 13% increased stroke risk 6. The presence of carotid plaques, particularly echolucent (unstable) plaques, predicts cerebrovascular events independent of traditional risk factors 3, 11.
Histological Correlates
At the tissue level, subclinical atherosclerosis encompasses several plaque types 2:
- Pathological intimal thickening (earliest lesion with lipid pools)
- Fibroatheroma
- Thin-cap fibroatheroma
- Healed plaque ruptures
- Fibrocalcific plaque
Importantly, coronary calcification indicates atherosclerosis but is neither a marker of plaque stability nor instability 3. Atherosclerotic arteries don't always show calcifications, though calcification extent correlates with total plaque burden 3, 11.
Common Pitfalls
Misunderstanding coronary calcium: Presence of calcium proves "coronary disease" (atherosclerosis) but doesn't necessarily indicate hemodynamically significant stenosis (≥50% narrowing). Specificity for significant stenosis is only 50% 3.
Not all atherosclerosis is visible: Atherosclerotic diseased arteries don't necessarily show calcifications 11. Non-calcified plaques require CT angiography for detection 1, 5.
Age and context matter: Normal CIMT values vary by age, sex, and ethnicity. Values must be interpreted using appropriate percentiles 6, 12.
Recommended Imaging Approach
For individuals aged ≥40 years with intermediate risk (7.5-20% 10-year ASCVD risk): CAC scoring is the preferred first-line modality 1, 4, 5.
For younger adults (35-40 years) with borderline risk: Carotid ultrasound may be more advantageous as coronary calcification develops later 5.
For older adults or those with peripheral symptoms: ABI measurement provides useful risk stratification 3, 6.
The 2021 ACR guidelines categorize CAC scoring as "usually appropriate" for asymptomatic patients at elevated cardiovascular risk 1. The 2012 European guidelines support imaging methods as relevant for CVD risk assessment in individuals at moderate risk 3.